Keywords: DHP، دی هیدروپیریدین; ABC, ATP-binding cassette; MDR, multidrug resistance; P-gp, P-glycoprotein; DHP, dihydropyridine; CCB, calcium channel blocking; MTT, thiazolyl blue tetrazolium bromide; Rh123, rhodamine 123.1,4-Dihydropyridine (CID 104822); Multidrug resistance; Cytotoxi
مقالات ISI DHP، دی هیدروپیریدین (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: DHP، دی هیدروپیریدین; AP, action potential; APD, action potential duration; APD60, action potential duration at 60% level of repolarization; AMP, amplitude; AA, arachidonic acid; APIII, antipyrylazo III; BSA, bovine serum albumin; DMSO, dimethylsulphoxide; DHP, dihydropyridine
A chiral LC–MS/MS method for the stereospecific determination of efonidipine in human plasma
Keywords: DHP، دی هیدروپیریدین; LLE, liquid-liquid extraction; DHP, dihydropyridine; CKD, chronic kidney disease; BP, blood pressure; MBF, medullary blood flux; IS, internal standard; ESI, electrospray ionization; CAD, collision activated dissociation; EP, entrance potential; CXP, colli
Determination of efonidipine in human plasma by LC–MS/MS for pharmacokinetic applications
Keywords: DHP، دی هیدروپیریدین; DHP, dihydropyridine; HR, heart rate; CKD, chronic kidney disease; BP, blood pressure; IS, internal standard; LLOQ, lower limit of quantification; QC, quality control; ULOQ, upper limit of quantification; ESI, electrospray ionization; DP, declustering pot
Drug–Drug Interactions in Cardiovascular Catheterizations and Interventions
Keywords: DHP، دی هیدروپیریدین; anticoagulants; drug-drug interactions; polypharmacyACS, acute coronary syndromes; AUC, area under the curve; CCB, calcium channel blocker; COX, cyclooxygenase; DDI, drug–drug interactions; DHP, dihydropyridine; FDA, U.S. Food and Drug Administration; GI,
Novel therapies in acute and chronic heart failure
Keywords: DHP، دی هیدروپیریدین; ACE, Angiotensin converting enzyme; ADHF, Acute decompensated heart failure; AGEs, Advanced glycation end-products; ARB, Angiotensin receptor blockers; BNP, Brain natriuretic peptide; CAMKII, calmodulin-dependent kinase II; DHP, Dihydropyridine; DRI, Dire
The role of calcium and mitochondrial oxidant stress in the loss of substantia nigra pars compacta dopaminergic neurons in Parkinson's disease
Keywords: DHP، دی هیدروپیریدین; Parkinson's disease; pacemaking; calcium; endoplasmic reticulum; mitochondrial oxidant stress; l-type channelsDA, dopaminergic; DHP, dihydropyridine; ER, endoplasmic reticulum; LB, Lewy body; LC, locus ceruleus; mito-roGFP, mitochondrially-targeted redox-
Drugs from slugs—Past, present and future perspectives of ω-conotoxin research
Keywords: DHP، دی هیدروپیریدین; αα, amino acid; ACh, acetylcholine; CHMP, Committee for Medicinal Products for Human Use; CNS, central nervous system; DHP, dihydropyridine; FDA, Food and Drug Administration, USA; Fmoc, 9-fluorenylmethyl; Hyp, 4-trans-hydroxyproline; IND, investigational
Condensed 1,4-dihydropyridines with various esters and their calcium channel antagonist activities
Keywords: DHP، دی هیدروپیریدین; Hexahydroquinoline; Furoquinoline; Calcium antagonistic activity; BiotransformationWHO, World Health Organization; DHP, dihydropyridine; HHQ, hexahydroquinoline; eNOS, endothelial nitric oxide synthase; COX, cyclooxygenase; l-NAME, Nω-nitro-l-arginine met
Autoantibodies to calcium channels in type 1 diabetes mediate autonomic dysfunction by different mechanisms in colon and bladder and are neutralized by antiidiotypic antibodies
Keywords: DHP، دی هیدروپیریدین; Type 1 diabetes; Autoantibodies; IVIg; Voltage-gated calcium channels; AutonomiaAbs, autoantibodies; DHP, dihydropyridine; IVIg, intravenous immunoglobulin; MMCs, migrating motor complexes; T1D, type 1 diabetes; VGCCs, voltage-gated calcium channels
Stimulatory role of calcium in rapid eye movement sleep deprivation–induced noradrenaline-mediated increase in Na-K-ATPase activity in rat brain
Keywords: DHP، دی هیدروپیریدین; brain excitability; Ca2+; lipid peroxidation; Na-K-ATPase; noradrenaline; REM sleepCa2+, calcium; CLN, clonidine; Ctl, control; CyA, cyclopiazonic acid; DHP, dihydropyridine; DMSO, dimethylsulfoxide; EDTA, ethylene diaminetetraacetic acid; EGTA, ethylene
Critical amino acid residues of maurocalcine involved in pharmacology, lipid interaction and cell penetration
Keywords: DHP، دی هیدروپیریدین; BSA, bovine serum albumin; CGN, cerebellar granule neurons; CHO, chinese hamster ovary; CPP, cell penetrating peptide; DHE, dihydroethidium; DHP, dihydropyridine; DHPR, dihydropyridine receptor; DMEM, dulbecco’s modified eagle’s medium; DMSO, dimethyl sul
Effects of nimodipine, an L-type calcium channel antagonist, on the chicken’s cochlear potentials
Keywords: DHP، دی هیدروپیریدین; Ca2+, calcium; CAP, compound action potential; CM, cochlear microphonic; DHP, dihydropyridine; K+, potassium; SP, summating potential; VGCC, voltage-gated calcium channelL-type calcium channel; Hair cell; Neurotransmitter release; Nimodipine; Chicken; Coc
L-type calcium channel ligands block nicotine-induced signaling to CREB by inhibiting nicotinic receptors
Keywords: DHP، دی هیدروپیریدین; Nicotine; Nicotinic acetylcholine receptor; Calcium channel; Signaling; Dihydropyridine; CREBCREB, cyclic-AMP response element-binding protein; DHP, dihydropyridine; LTCC, L-type calcium channel; nAChR, nicotinic acetylcholine receptor; pCREB, phospho-CRE
Receptor-independent actions of cannabinoids on cell membranes: Focus on endocannabinoids
Keywords: DHP، دی هیدروپیریدین; 2-AG, 2-arachidonoylglycerol; ACh, acetylcholine; AA, arachidonic acid; AEA, N-arachidonoylethanolamine, anandamide; COX, cyclooxygenase; DHP, dihydropyridine; FAAH, fatty acid amide hydrolase; GPCR, G-protein coupled receptor; LGIC, ligand-gated ion chan